Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses.

Spencer S, Köstel Bal S, Egner W, Lango Allen H, Raza SI, Ma CA, Gürel M, Zhang Y, Sun G, Sabroe RA, Greene D, Rae W, Shahin T, Kania K, Ardy RC, Thian M, Staples E, Pecchia-Bekkum A, Worrall WPM, Stephens J, Brown M, Tuna S, York M, Shackley F, Kerrin D, Sargur R, Condliffe A, Tipu HN, Kuehn HS, Rosenzweig SD, Turro E, Tavaré S, Thrasher AJ, Jodrell DI, Smith KGC, Boztug K, Milner JD, Thaventhiran JED.

J Exp Med. 2019 Jun 24. pii: jem.20190344. doi: 10.1084/jem.20190344. [Epub ahead of print]

PMID:
31235509
2.

Flucloxacillin Hypersensitivity: Patient Outcomes in a Multicenter Retrospective Study.

Kennard L, Rutkowski K, Siew LQC, Nakonechna A, Sargur R, Egner W, Shrimpton A, Mirakian R, Wagner A.

J Allergy Clin Immunol Pract. 2019 Mar 25. pii: S2213-2198(19)30282-X. doi: 10.1016/j.jaip.2019.03.018. [Epub ahead of print]

PMID:
30922988
3.

British Society for Immunology/United Kingdom Primary Immunodeficiency Network consensus statement on managing non-infectious complications of common variable immunodeficiency disorders.

Bethune C, Egner W, Garcez T, Huissoon A, Jolles S, Karim Y, Jain R, Savic S, Kelley K, Grosse-Kreul D, Grigoriadou S.

Clin Exp Immunol. 2019 Jun;196(3):328-335. doi: 10.1111/cei.13272. Epub 2019 Mar 7.

4.

Anaesthesia, surgery, and life-threatening allergic reactions: management and outcomes in the 6th National Audit Project (NAP6).

Harper NJN, Cook TM, Garcez T, Lucas DN, Thomas M, Kemp H, Kong KL, Marinho S, Karanam S, Ferguson K, Hitchman J, Torevell H, Warner A, Egner W, Nasser S, McGuire N, Bellamy M, Floss K, Farmer L, Farooque S.

Br J Anaesth. 2018 Jul;121(1):172-188. doi: 10.1016/j.bja.2018.04.015. Epub 2018 May 21.

5.

Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6).

Harper NJN, Cook TM, Garcez T, Farmer L, Floss K, Marinho S, Torevell H, Warner A, Ferguson K, Hitchman J, Egner W, Kemp H, Thomas M, Lucas DN, Nasser S, Karanam S, Kong KL, Farooque S, Bellamy M, McGuire N.

Br J Anaesth. 2018 Jul;121(1):159-171. doi: 10.1016/j.bja.2018.04.014. Epub 2018 May 21.

6.

Cross-sectional study of perioperative drug and allergen exposure in UK practice in 2016: the 6th National Audit Project (NAP6) Allergen Survey.

Marinho S, Kemp H, Cook TM, Farmer L, Farooque S, Lucas DN, Garcez T, Floss K, Torevell H, Thomas M, Warner A, Hitchman J, Ferguson K, Egner W, Nasser S, Karanam S, Kong KL, McGuire N, Bellamy M, Harper NJN.

Br J Anaesth. 2018 Jul;121(1):146-158. doi: 10.1016/j.bja.2018.04.016. Epub 2018 May 21.

7.

An observational national study of anaesthetic workload and seniority across the working week and weekend in the UK in 2016: the 6th National Audit Project (NAP6) Activity Survey.

Kemp H, Marinho S, Cook TM, Farmer L, Bellamy M, Egner W, Farooque S, Ferguson K, Floss K, Garcez T, Karanam S, Hitchman J, Kong KL, McGuire N, Nasser S, Lucas DN, Thomas M, Torevell H, Warner A, Harper NJN.

Br J Anaesth. 2018 Jul;121(1):134-145. doi: 10.1016/j.bja.2018.04.010. Epub 2018 May 21.

8.

Anaesthesia, surgery, and life-threatening allergic reactions: protocol and methods of the 6th National Audit Project (NAP6) of the Royal College of Anaesthetists.

Cook TM, Harper NJN, Farmer L, Garcez T, Floss K, Marinho S, Torevell H, Warner A, McGuire N, Ferguson K, Hitchman J, Egner W, Kemp H, Thomas M, Lucas DN, Nasser S, Karanam S, Kong KL, Farooque S, Bellamy M, McGlennan A, Moonesinghe SR.

Br J Anaesth. 2018 Jul;121(1):124-133. doi: 10.1016/j.bja.2018.04.001. Epub 2018 May 21.

9.

Specialist perioperative allergy clinic services in the UK 2018: Results from the Royal College of Anaesthetists Sixth National Audit Project (NAP6) investigation of perioperative anaphylaxis.

Egner W, Cook TM, Garcez T, Marinho S, Kemp H, Lucas DN, Floss K, Farooque S, Torevell H, Thomas M, Ferguson K, Nasser S, Karanam S, Kong KL, McGuire N, Bellamy M, Warner A, Hitchman J, Farmer L, Harper NJN.

Clin Exp Allergy. 2018 Jul;48(7):846-861. doi: 10.1111/cea.13180. Epub 2018 Jun 19.

10.

Prevalence and clinical challenges among adults with primary immunodeficiency and recombination-activating gene deficiency.

Lawless D, Geier CB, Farmer JR, Lango Allen H, Thwaites D, Atschekzei F, Brown M, Buchbinder D, Burns SO, Butte MJ, Csomos K, Deevi SVV, Egner W, Ehl S, Eibl MM, Fadugba O, Foldvari Z, Green DM, Henrickson SE, Holland SM, John T, Klemann C, Kuijpers TW, Moreira F, Piller A, Rayner-Matthews P, Romberg ND, Sargur R, Schmidt RE, Schröder C, Schuetz C, Sharapova SO, Smith KGC, Sogkas G, Speckmann C, Stirrups K, Thrasher AJ, Wolf HM, Notarangelo LD, Anwar R, Boyes J, Ujhazi B; NIHR BioResource–Rare Diseases Consortium, Thaventhiran J, Walter JE, Savic S.

J Allergy Clin Immunol. 2018 Jun;141(6):2303-2306. doi: 10.1016/j.jaci.2018.02.007. Epub 2018 Mar 2. No abstract available.

11.

Specialist perioperative allergy clinic services in the UK 2016: Results from the Royal College of Anaesthetists Sixth National Audit Project.

Egner W, Cook T, Harper N, Garcez T, Marinho S, Kong KL, Nasser S, Thomas M, Warner A, Hitchman J, Floss K; Sixth national audit project (NAP6) steering & Case Review panel, RCoA.

Clin Exp Allergy. 2017 Oct;47(10):1318-1330. doi: 10.1111/cea.12993. Epub 2017 Sep 7.

12.

An international survey on anti-neutrophil cytoplasmic antibodies (ANCA) testing in daily clinical practice.

Damoiseaux J, Heijnen I, Van Campenhout C, Eriksson C, Fabien N, Herold M, van der Molen RG, Egner W, Patel D, Plaza-Lopez A, Radice A, de Sousa MJR, Viander M, Shoenfeld Y.

Clin Chem Lab Med. 2018 Sep 25;56(10):1759-1770. doi: 10.1515/cclm-2017-0306. No abstract available.

PMID:
28710880
13.

UK NEQAS survey of allergen component testing across the United Kingdom and other European countries.

Saleem R, Keymer C, Patel D, Egner W, Rowbottom AW.

Clin Exp Immunol. 2017 Jun;188(3):387-393. doi: 10.1111/cei.12950. Epub 2017 Apr 19.

14.

British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders.

Hurst JR, Verma N, Lowe D, Baxendale HE, Jolles S, Kelleher P, Longhurst HJ, Patel SY, Renzoni EA, Sander CR, Avery GR, Babar JL, Buckland MS, Burns S, Egner W, Gompels MM, Gordins P, Haddock JA, Hart SP, Hayman GR, Herriot R, Hoyles RK, Huissoon AP, Jacob J, Nicholson AG, Rassl DM, Sargur RB, Savic S, Seneviratne SL, Sheaff M, Vaitla PM, Walters GI, Whitehouse JL, Wright PA, Condliffe AM.

J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):938-945. doi: 10.1016/j.jaip.2017.01.021. Epub 2017 Mar 25. Review.

15.

Chlorhexidine allergy in four specialist allergy centres in the United Kingdom, 2009-13: clinical features and diagnostic tests.

Egner W, Helbert M, Sargur R, Swallow K, Harper N, Garcez T, Savic S, Savic L, Eren E.

Clin Exp Immunol. 2017 Jun;188(3):380-386. doi: 10.1111/cei.12944. Epub 2017 Mar 13.

16.

A 17-year experience in perioperative anaphylaxis 1998-2015: harmonizing optimal detection of mast cell mediator release.

Egner W, Sargur R, Shrimpton A, York M, Green K.

Clin Exp Allergy. 2016 Nov;46(11):1465-1473. doi: 10.1111/cea.12785. Epub 2016 Sep 21.

17.

Adherence to recommended UK sampling protocols for detecting mast cell mediator release in perioperative anaphylaxis.

Egner W.

J Clin Pathol. 2017 Jan;70(1):85-88. doi: 10.1136/jclinpath-2016-204038. Epub 2016 Sep 28.

PMID:
27681845
18.

Falsely low immunoglobulin (Ig)G4 in routine analysis: how not to miss IgG4 disease.

Egner W, Swallow K, Lock RJ, Patel D.

Clin Exp Immunol. 2016 Oct;186(1):57-63. doi: 10.1111/cei.12805. Epub 2016 Aug 9.

19.

The prozone effect in serum assays for IgG4: comment on the article by Khosroshahi et al.

Lock RJ, Wallage MJ, Patel D, Swallow K, Egner W.

Arthritis Rheumatol. 2014 Nov;66(11):3246-7. doi: 10.1002/art.38752. No abstract available.

20.

Cerebrospinal fluid total protein cannot reliably distinguish true subarachnoid haemorrhage from other causes of raised cerebrospinal fluid net bilirubin and net oxyhaemoglobin absorbances.

Birch K, Burrows G, Cruickshank A, Egner W, Holbrook I, Lewis E, McNeilly J, Patel D, Worthington V.

Ann Clin Biochem. 2014 Nov;51(Pt 6):657-61. doi: 10.1177/0004563214538949. Epub 2014 May 20.

PMID:
24847134
21.

The 3rd International Standard for serum IgE: international collaborative study to evaluate a candidate preparation.

Thorpe SJ, Heath A, Fox B, Patel D, Egner W.

Clin Chem Lab Med. 2014 Sep;52(9):1283-9. doi: 10.1515/cclm-2014-0243.

PMID:
24807170
22.

High-titre circulating tissue transglutaminase-2 antibodies predict small bowel villous atrophy, but decision cut-off limits must be locally validated.

Beltran L, Koenig M, Egner W, Howard M, Butt A, Austin MR, Patel D, Sanderson RR, Goubet S, Saleh F, Lavender J, Stainer E, Tarzi MD.

Clin Exp Immunol. 2014 May;176(2):190-8. doi: 10.1111/cei.12249.

23.

Serological testing for coeliac disease in Type 1 diabetes mellitus: is immunoglobulin A level measurement necessary?

Kurien M, Leeds JS, Hopper AD, Wild G, Egner W, Tesfaye S, Hadjivassiliou M, Sanders DS.

Diabet Med. 2013 Jul;30(7):840-5. doi: 10.1111/dme.12163. Epub 2013 Apr 5.

PMID:
23461783
24.

Defining the impact of individual sample variability on routine immunoassay of serum free light chains (sFLC) in multiple myeloma.

Murng SH, Follows L, Whitfield P, Snowden JA, Swallow K, Green K, Sargur R, Egner W.

Clin Exp Immunol. 2013 Feb;171(2):201-9. doi: 10.1111/cei.12011.

25.

Quality not quantity for transglutaminase antibody 2: the performance of an endomysial and tissue transglutaminase test in screening coeliac disease remains stable over time.

Swallow K, Wild G, Sargur R, Sanders DS, Aziz I, Hopper AD, Egner W.

Clin Exp Immunol. 2013 Jan;171(1):100-6. doi: 10.1111/cei.12000.

26.

ESPGHAN guidance on coeliac disease 2012: multiples of ULN for decision making do not harmonise assay performance across centres.

Egner W, Shrimpton A, Sargur R, Patel D, Swallow K.

J Pediatr Gastroenterol Nutr. 2012 Dec;55(6):733-5. doi: 10.1097/MPG.0b013e31826531f6.

PMID:
22744189
27.

Thyroid peroxidase antibody in women with unexplained recurrent miscarriage: prevalence, prognostic value, and response to empirical thyroxine therapy.

Yan J, Sripada S, Saravelos SH, Chen ZJ, Egner W, Li TC.

Fertil Steril. 2012 Aug;98(2):378-82. doi: 10.1016/j.fertnstert.2012.04.025. Epub 2012 May 22.

PMID:
22624672
28.

The UKNEQAS scheme for cerebrospinal fluid haem pigments: a paradigm for service improvement.

Beetham R, Egner W, Patel D.

Ann Clin Biochem. 2011 Nov;48(Pt 6):489-97. doi: 10.1258/acb.2011.011031. Epub 2011 Sep 23.

PMID:
21948489
29.

Raised tryptase without anaphylaxis or mastocytosis: heterophilic antibody interference in the serum tryptase assay.

Sargur R, Cowley D, Murng S, Wild G, Green K, Shrimpton A, Egner W.

Clin Exp Immunol. 2011 Mar;163(3):339-45. doi: 10.1111/j.1365-2249.2010.04287.x.

30.

Susceptibility to mycobacterial infection in a young man with a hypoglossal nerve palsy: the hunt for an immunological defect.

Cottle LE, Sargur R, Egner W, Shackley F, Greig J.

JRSM Short Rep. 2010 Jul 30;1(2):21. doi: 10.1258/shorts.2010.010018. No abstract available.

31.

Allergy--will we ever meet the unmet need?

Finlay I, Egner W.

J R Soc Med. 2010 Nov;103(11):430-1. doi: 10.1258/jrsm.2010.100253. No abstract available.

32.

NOD2 polymorphisms in clinical phenotypes of common variable immunodeficiency disorders.

Packwood K, Drewe E, Staples E, Webster D, Witte T, Litzman J, Egner W, Sargur R, Sewell W, Lopez-Granados E, Seneviratne SL, Powell RJ, Ferry BL, Chapel HM.

Clin Exp Immunol. 2010 Sep;161(3):536-41. doi: 10.1111/j.1365-2249.2010.04216.x.

33.

Cryoglobulin evaluation: best practice?

Sargur R, White P, Egner W.

Ann Clin Biochem. 2010 Jan;47(Pt 1):8-16. doi: 10.1258/acb.2009.009180. Review.

PMID:
20040797
34.

Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen.

Alimohammadi M, Dubois N, Sköldberg F, Hallgren A, Tardivel I, Hedstrand H, Haavik J, Husebye ES, Gustafsson J, Rorsman F, Meloni A, Janson C, Vialettes B, Kajosaari M, Egner W, Sargur R, Pontén F, Amoura Z, Grimfeld A, De Luca F, Betterle C, Perheentupa J, Kämpe O, Carel JC.

Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4396-401. doi: 10.1073/pnas.0809986106. Epub 2009 Feb 26.

35.

Revised national guidelines for analysis of cerebrospinal fluid for bilirubin in suspected subarachnoid haemorrhage.

Cruickshank A, Auld P, Beetham R, Burrows G, Egner W, Holbrook I, Keir G, Lewis E, Patel D, Watson I, White P; UK NEQAS Specialist Advisory Group for External Quality Assurance of CSF Proteins and Biochemistry.

Ann Clin Biochem. 2008 May;45(Pt 3):238-44. doi: 10.1258/acb.2008.007257.

PMID:
18482910
36.

What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis.

Hopper AD, Hadjivassiliou M, Hurlstone DP, Lobo AJ, McAlindon ME, Egner W, Wild G, Sanders DS.

Clin Gastroenterol Hepatol. 2008 Mar;6(3):314-20. doi: 10.1016/j.cgh.2007.12.008.

PMID:
18328437
37.

A critical appraisal of current practice in the detection, analysis, and reporting of cryoglobulins.

Vermeersch P, Gijbels K, Mariën G, Lunn R, Egner W, White P, Bossuyt X.

Clin Chem. 2008 Jan;54(1):39-43. Epub 2007 Nov 12.

38.

National audit of cerebrospinal fluid testing.

Holbrook I, Beetham R, Cruickshank A, Egner W, Fahie-Wilson M, Keir G, Patel D, Watson I, White P.

Ann Clin Biochem. 2007 Sep;44(Pt 5):443-8.

PMID:
17761029
39.

Cerebrospinal fluid spectrophotometry of bilirubin, not the Xanthochromic Index, for the detection of CT-negative sub-arachnoid haemorrhage.

Watson ID, Beetham R, Keir G, Cruickshank AM, Holbrook IB, Fahie-Wilson MN, White PA, Patel D, Egner W.

J Clin Neurosci. 2007 Jun;14(6):608-9. Epub 2006 May 2. No abstract available.

PMID:
16647856
40.
41.

Survey of clinical allergy services provided by clinical immunologists in the UK.

El-Shanawany TM, Arnold H, Carne E, Misbah SA, Egner W, Wallington TB, Herriot R, Williams PE.

J Clin Pathol. 2005 Dec;58(12):1283-90.

42.

Do serum levels of eosinophil granule-derived protein change in patients undergoing pelvic radiotherapy?

Bowen JM, Newbold K, Blake P, Wild G, Egner W, Norman AR, Andreyev HJ.

Clin Oncol (R Coll Radiol). 2005 Aug;17(5):382-4.

PMID:
16097571
43.

Spectrophotometry of cerebrospinal fluid in suspected subarachnoid haemorrhage.

Cruickshank A, Beetham R, Holbrook I, Watson I, Wenham P, Keir G, White P, Egner W.

BMJ. 2005 Jan 15;330(7483):138. No abstract available.

44.

The national survey of adverse reactions to dental materials in the UK: a preliminary study by the UK Adverse Reactions Reporting Project.

Scott A, Egner W, Gawkrodger DJ, Hatton PV, Sherriff M, van Noort R, Yeoman C, Grummitt J.

Br Dent J. 2004 Apr 24;196(8):471-7; discussion 465.

PMID:
15105862
45.

Adverse reactions to protective gloves used in the dental profession: experience of the UK Adverse Reaction Reporting Project.

Scott A, Gawkrodger DJ, Yeoman C, Egner W, van Noort R, Hatton PV, Grummitt J.

Br Dent J. 2003 Dec 20;195(12):686-90.

PMID:
14718955
46.

Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies.

Wolf HH, Davies SV, Borte M, Caulier MT, Williams PE, Bernuth HV, Egner W, Sklenar I, Adams C, Späth P, Morell A, Andresen I.

Vox Sang. 2003 Jan;84(1):45-53.

PMID:
12542733
47.

Juvenile dermatomyositis associated with hereditary angioneurotic oedema.

Narasimhan R, Lakshman R, Amos RS, Williams LH, Egner W, Finn A.

Arch Dis Child. 2002 Dec;87(6):563. No abstract available.

48.
49.
50.

Two episodes of life-threatening anaphylaxis in the same patient to a chlorhexidine-sulphadiazine-coated central venous catheter.

Stephens R, Mythen M, Kallis P, Davies DW, Egner W, Rickards A.

Br J Anaesth. 2001 Aug;87(2):306-8.

Supplemental Content

Support Center